Actively Recruiting

Phase 1
Age: 18Years - 89Years
All Genders
Healthy Volunteers
NCT04537403

PET Detection of CCR2 in Human Atherosclerosis

Led by Washington University School of Medicine · Updated on 2025-08-01

100

Participants Needed

1

Research Sites

256 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

CONDITIONS

Official Title

PET Detection of CCR2 in Human Atherosclerosis

Who Can Participate

Age: 18Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Normal volunteers aged 18-40 years who do not smoke and have no history of diabetes, hypertension, or high cholesterol
  • Patients aged 50-89 years with adequate nutrition, with or without smoking history, diabetes, hypertension, or high cholesterol
  • Both asymptomatic and symptomatic patients with known carotid artery atherosclerosis greater than 70% who are scheduled for surgery
  • Patients with advanced peripheral artery disease
Not Eligible

You will not qualify if you...

  • Unable to provide and sign informed consent
  • Currently enrolled in another study
  • Patients with type 1 diabetes or septic shock
  • Receiving steroid therapy
  • Recent history of heavy alcohol use (males more than 2 drinks per day, females more than 1 drink per day)
  • Following extreme diets such as Atkins or South Beach diet
  • Stage 4 chronic renal failure
  • Unstable clinical condition as judged by the principal investigator
  • Unable to tolerate 60 minutes lying on back with arms at sides
  • Contraindications to MRI (e.g., pacemaker, brain aneurysm clips, shrapnel)
  • Positive pregnancy test or currently breastfeeding
  • Other conditions such as cancer or autoimmune/inflammatory diseases like rheumatoid arthritis or multiple sclerosis that increase CCR2 expression

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University CCIR

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

K

Kitty Harrison, BSN, RN

CONTACT

R

Robert Gropler, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here